The J.P. Morgan Healthcare Conference opened Tuesday with GlaxoSmithKline CEO Emma Walmsley’s rundown, featuring—of course—its $5 billion Tesaro buy. And you could say that Amgen CEO Bob Bradway’s presentation began late Monday, when the company rolled out another round of
read moreAs part of Fujifilm’s $90 million plans to grow its CDMO business, the Japanese company said it will expand its production facility in North Carolina. More: Fujifilm rolls out more plans to expand its CDMO footprint with expansion of North
read moreIn a landmark case for pharma, Merck & Co. might just have convinced the Supreme Court that it did its duty by Fosamax patients, despite its failure to update the drug’s label with fracture risks. More: Pharma nears landmark win
read moreIndian drugmaker Aurobindo issued a voluntary recall of 80 lots of valsartan tablets of the compound due to the detection of trace amounts of an impurity found in the finished product. More: Valsartan recall expands with Aurobindo issuing recall of
read moreThe U.S. Supreme Court declined to hear Gilead’s appeal in a whistleblower case against the company. But the court also refused to take up Merck’s appeal in a long-running dispute with Gilead over its patents to hepatitis C blockbusters—a victory
read moreAstraZeneca has appointed “world-renowned oncology scientist” José Baselga as the new head of its research and development unit for Oncology. More: José Baselga new AstraZeneca head of R&D Oncology Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals